Levomilnacipran hydrochloride is mainly used to treat Major Depressive Disorder (MDD) in adults, working as a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) to boost mood-regulating neurotransmitters in the brain, but it’s also sometimes explored for conditions like fibromyalgia and neuropathic pain, although its main indication is depression. It is grouped under the following drug class(es): Neurotransmitter agents, Serotonin agents and SNRIs. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fetzima, Savella and Joncia. Its PubChem CID is 6917778.
Levomilnacipran hydrochloride
| CAS No | 175131-60-9 |
|---|---|
| Molecular Formula | C15H23ClN2O |
| Molecular Weight | 282.81 g/mol |
| Synonyms | cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Levomilnacipran hydrochloride is mainly used to treat Major Depressive Disorder (MDD) in adults, working as a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) to boost mood-regulating neurotransmitters in the brain, but it's also sometimes explored for conditions like fibromyalgia and neuropathic pain, although its main indication is depression.
The listed CAS number is 175131-60-9.
The listed molecular formula is C15H23ClN2O.
The listed molecular weight is 282.81 g/mol.
cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride.
The source lists Fetzima, Savella and Joncia.